Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
deals
life sciences
national blog main
national top stories
5
×
new york blog main
new york top stories
5
×
san francisco blog main
san francisco top stories
startups
biotech
boston blog main
boston top stories
vc
fda
healthcare
medical devices
roboticsai
san diego blog main
san diego top stories
san francisco
wisconsin blog main
wisconsin top stories
accelerator
acetylon pharmaceuticals
airbnb
alex gorsky
amazon web services (aws)
ambys medicines
artificial intelligence (a.i.)
ashley mcevoy
athelas
atomwise
auris health
azacitidine
benchling
beta-thalassemia
biotechnology
boston
cancer
cell therapy
What
startup
5
×
deal
big
biotech
companies
medical
medicines
new
acquiring
admits
ago
aiming
aims
ambys
appear
approach
auris
based
biggest
billion
biotechs
builds
buy
called
cash
classes
combinator
company’s
control
deadly
debuted
debuts
deerfield
developer
developing
didn't
diseases
drugs
dug
end
Language
unset
Current search:
startup
×
" national top stories "
×
" new york top stories "
×
@xconomy.com
4 years ago
Five Years After Y Combinator First Admits Biotechs, They’re Dug In
@xconomy.com
4 years ago
Flagship’s Omega Aims to Take Epigenetic Drugs a Step Further
@xconomy.com
5 years ago
Johnson & Johnson to Buy Robotics Startup Auris Health for $3.4B
@xconomy.com
5 years ago
After Deal Stalled, Shine Medical Eyeing Up to $160M from Deerfield
@xconomy.com
5 years ago
With Big Takeda Deal at Launch, Can Ambys Keep Control of Its Future?